Dr. Claus Roehrborn, MD
What this data tells you about Dr. Roehrborn
Dr. Claus Roehrborn is an urology physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Roehrborn performed 5,151 Medicare services across 2,566 unique beneficiaries.
Between the years covered by Open Payments, Dr. Roehrborn received a total of $254,274 from 26 pharmaceutical and/or device companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roehrborn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,685 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
875 | $88 | $344 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 533 | $134 | $2,030 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $57 | $232 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
331 | $8 | $80 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
309 | $10 | $340 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 140 | $3 | $395 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $113 | $533 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
95 | $25 | $143 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
74 | $104 | $458 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
57 | $70 | $468 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
53 | $183 | $920 |
| Injection, garamycin, gentamicin, up to 80 mg | 49 | $2 | $14 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
48 | $3 | $18 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
46 | $258 | $3,223 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
46 | $924 | $7,119 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $135 | $464 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
41 | $556 | $3,303 |
| Simple change of bladder tube | 34 | $69 | $448 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
34 | $811 | $2,355 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $83 | $347 |
| New patient office visit, complex (60-74 min) | 29 | $159 | $664 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
25 | $176 | $837 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
25 | $100 | $212 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
21 | $49 | $309 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
18 | $57 | $346 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $60 | $138 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Roehrborn is a clinical cardiology specialist, with above-average Medicare volume (top 22% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Roehrborn experienced with bcg treatment for bladder cancer?
Does Dr. Roehrborn receive payments from pharmaceutical companies?
How do Dr. Roehrborn's costs compare to other urology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology